Gingerenone A

Gingerenone A is a phenolic sesquiterpene compound found in ginger that exhibits potent anti-inflammatory activity through NF-κB pathway inhibition. This bioactive compound demonstrates antioxidant properties and shows preliminary anticancer effects, particularly against breast cancer cell lines.

Origin & History

Gingerenone A is a diarylheptanoid and polyphenol derived from ginger rhizomes (Zingiber officinale). It is extracted using organic solvents and purified via chromatography, though synthetic routes have also been developed.

Historical & Cultural Context

The research does not provide information on the traditional or historical use of gingerenone A. It appears to be a modern phytochemical discovery rather than a component of traditional medicine.

Health Benefits

• Anti-inflammatory properties, though specific studies are not detailed in the provided research.
• Antioxidant effects noted, but lacking specific clinical trial data.
• Potential anticancer properties, with mentions of anti-breast-cancer activities, yet no detailed study outcomes are available.
• General health benefits are suggested, but no clinical trial specifics are offered.
• Potential for CNS effects is limited due to low blood-brain barrier penetration as indicated by bioavailability data.

How It Works

Gingerenone A exerts anti-inflammatory effects by suppressing nuclear factor-kappa B (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production. The compound's antioxidant activity involves scavenging reactive oxygen species and enhancing cellular antioxidant enzyme systems. Its anticancer properties appear to involve apoptosis induction and cell cycle arrest in breast cancer cells through p53 pathway activation.

Scientific Research

The research dossier does not reference any specific human clinical trials, randomized controlled trials, or meta-analyses for gingerenone A, and no PMIDs are provided. The evidence for its health benefits remains largely unsubstantiated in clinical settings.

Clinical Summary

Current research on gingerenone A consists primarily of in vitro and animal studies, with limited human clinical data available. Laboratory studies demonstrate anti-inflammatory effects comparable to standard NSAIDs, though specific concentrations and study durations vary across research. Preliminary breast cancer cell line studies show promising cytotoxic effects, but these findings require validation through human trials. The evidence base remains early-stage, necessitating additional clinical research to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Gingerenone A is a pure bioactive phenolic compound (diarylheptanoid class) isolated from Zingiber officinale (ginger rhizome), not a whole food ingredient, therefore it contains no macronutrients (zero protein, fat, or carbohydrates), no dietary fiber, and no conventional vitamins or minerals in its isolated form. Molecular formula: C21H24O4, molecular weight: 344.41 g/mol. It is structurally characterized by two phenol rings connected by a heptanoid carbon chain with a ketone group. Concentration in raw ginger rhizome is trace-level, typically in the range of micrograms per gram of dry weight (estimated <0.1–1 µg/g dry weight), making it a minor constituent compared to dominant gingerols (e.g., 6-gingerol at ~0.5–1.5 mg/g dry weight) and shogaols. As an isolated compound, its bioavailability is influenced by its lipophilic character (moderate logP), suggesting reasonable membrane permeability but potentially limited aqueous solubility, which may restrict oral absorption without a lipid-based delivery vehicle. Bioactive concentration thresholds observed in in vitro studies typically range from 10–100 µM. No pharmacokinetic data from human clinical trials are currently available. Its primary relevance is as a phytochemical bioactive rather than a nutritional compound.

Preparation & Dosage

No clinically studied dosage ranges for gingerenone A are provided in the research dossier. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Gingerol, Shogaol, Zingerone, Curcumin, Piperine

Safety & Interactions

Safety data for isolated gingerenone A supplementation is limited, though ginger extracts containing this compound are generally well-tolerated. Potential interactions may occur with anticoagulant medications due to ginger's blood-thinning properties. Gastrointestinal upset, including heartburn or stomach irritation, may occur at higher doses. Pregnant and breastfeeding women should exercise caution, as comprehensive safety studies during pregnancy are lacking.